GBA1 and Parkinson disease: This means that putative treatments for GBA1-PD may need to correct glucocerebrosidase folding and structure, or restore activity of dysfunctional pathways (such as the lysosome-autophagy system), rather than simply restoring glucocerebrosidase enzyme activity.